KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Other Accumulated Expenses (2018 - 2025)

Bristol Myers Squibb (BMY) has disclosed Other Accumulated Expenses for 15 consecutive years, with $17.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 3.01% to $17.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $17.6 billion, a 3.01% decrease, with the full-year FY2025 number at $17.6 billion, down 3.01% from a year prior.
  • Other Accumulated Expenses was $17.6 billion for Q4 2025 at Bristol Myers Squibb, down from $19.3 billion in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $19.3 billion in Q3 2025 to a low of $12.4 billion in Q1 2022.
  • A 5-year average of $15.2 billion and a median of $14.9 billion in 2022 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: fell 19.19% in 2021, then grew 22.48% in 2024.
  • Bristol Myers Squibb's Other Accumulated Expenses stood at $14.0 billion in 2021, then rose by 4.4% to $14.6 billion in 2022, then increased by 8.9% to $15.9 billion in 2023, then grew by 14.11% to $18.1 billion in 2024, then dropped by 3.01% to $17.6 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Other Accumulated Expenses are $17.6 billion (Q4 2025), $19.3 billion (Q3 2025), and $17.4 billion (Q2 2025).